Mirum Pharmaceuticals (MIRM) Q1 2026 Earnings

25FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.33
-0.2
-0.07
0.06

Details

Expected EPS
0.05551
Actual EPS
-0.1
Surprise EPS
-0.16
Surprise Percent
+280.15%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -0.1 per share for Q1 2026.

0 Comments

Share your thoughts